Cargando…
The miRNAs Role in Melanoma and in Its Resistance to Therapy
Melanoma is the less common but the most malignant skin cancer. Since the survival rate of melanoma metastasis is about 10–15%, many different studies have been carried out in order to find a more effective treatment. Although the development of target-based therapies and immunotherapeutic strategie...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037367/ https://www.ncbi.nlm.nih.gov/pubmed/32013263 http://dx.doi.org/10.3390/ijms21030878 |